SHMT2 and hepatocellular carcinoma: For instance, miR-615-5p regulates the tumorigenicity of hepatocellular carcinoma (HCC) by negatively affecting oncogene levels, such as those of the insulin-like growth factor 1 receptor, serine hydroxymethyltransferase 2, and hydroxyacid oxidase 2 [11–13].